UK 23:54 Saturday, 14 November 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
He will be back at Sharestock on 4 September 2027 after a two year break. Matt Earl, aka the Dark Destroyer, is, arguably, the UK's leading short seller. Uber modest Evil Banksta might argue, but Matt and his Shadowfall fund have a long line of big scalps including Wirecard, ASOS and THG. And Matt's return is another reason to book an early bird ticket NOW before prices go up - you can do so HERE. Matt is not the only reason to pitch up.
I am delayed by Welsh Rugby and Jaya's birthday party and a house full of screaming young girls. Then to bitcoin.
Platinum group metals and chrome concentrates company Tharisa (THS) has announced a further listing for its shares – this on the Namibia Securities Exchange and stated with it having “identified broadening and diversifying its investor base, and improving the liquidity of its shares, as priorities”.
Amaroq (AMRQ) has issued “Q3 2026 Operational and Financial Results” including “operations continuing to ramp up according to plan, supported by the favourable gold price environment… confidence in the mid range of full-year production guidance of 25 to 35 koz”. How positive is that from the valuation at a current 101p share price?
Following Tom Winnifrith launching the Great British Takeover stakes prize competition, I noted I would monitor the performance of the leading picks, 'The Takeover 12', until we have a contest winner. Most recently, last month it was some further performance improvement and it has since been the same again, though currently still behind the indices with they also slightly improving. The full detail follows...
Warpaint London (W7L) has issued a “Change of Adviser” announcement that “Shore Capital, the company’s nominated adviser, will now act as sole broker to the company”. What about this, with the shares at 181p comparing to above 270p early this year?
I start with poor Henry and then the amazing case of Davion Healthcare PLC which shows why shorters matter when regulators fail abysmally Then it is Nvidia (NVDA) and Red Rock Resources (RRR).
Packaging manufacturer Robinson plc (RBN) has announced “Mike Cusick, Chief Financial Officer and Company Secretary will leave the company to take up a post in another company”. What about this following a trading update from Robinson last month and its shares at 125p?
Panmure has left its target price and forecasts unchanged on Amaroq (AMRQ) after 3rd quarter numbers as you can see in the note below. But I really just don’t get it and here’s why I think its maths must be wrong.
Before we all laugh at Nasdaq for allowing this scandalburger to IPO on October 22 I should flag up that Davion Healthcare PLC (US:DAVI) is British and the chaps behind it are very well known to the regulators over here. The shares listed at $12.25- and now trade at $1.19. My target is $0.
DFS Furniture (DFS) has issued an “AGM Trading Statement” including that “proprietary banking data indicates that our core retail brands, DFS and Sofology, have continued to outperform the wider sector, reflecting the strength and resilience of the group”, so what about a current share price response to below 130p, 4.5% lower?
Veteran asset manager Ted Oakley warns that the current risk-reward setup in financial markets is unfavorable, with potential rewards of only 5-6% against risks of 25-30%. He believes earnings estimates for 2027 are too high, citing a slowdown in AI growth, a struggling real estate sector, and declining manufacturing.
Whenever I come up with a right wing conspiracy theory ( which a few years later is shown to be 100% true) the Mrs. says “I bet you read it in the daily mail” as if that was proof, even were it trye that it cannot be true. Today, as we delight in 70 hours of audio proof that Joe Biden was losing his marbles back in 2017 so before he was elected ( so vindicating we right wing conspiracy theorists yet again) I wish to consider the Daily Mail and weight loss jabs.
I am not saying there will be one in 2027 but I think Amaroq (AMRQ) should pay a nominal dividend and it could do so. One reader in particular, a Skinhead with AmaroqDerangementSyndrome, has argued it cannot, so, after the Q3 numbers yesterday let me address him first.
You know that I do not believe in e-tulips. The biggest argument the bulls make is “look at how much money I've made and you have missed out, you want to bet against me again sucker?” But..
